Doctor profile · Federal record
Dr. NUZHAT CHALISA, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: INTERNAL MEDICINE) · Endocrinology, Diabetes & Metabolism Physician · CHANNAHON, IL
- NPI 1184686909
- Accepts Medicare
- 33 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
25259 REED STREET
CHANNAHON, IL 60410
(815) 467-0555
fax (815) 467-9823 - Mailing address
-
725 SCHOOL ST STE A
MORRIS, IL 604501207
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- March 17, 2022
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (2)
- Illinois #036.114141 · Illinois #336-075122
- Medicaid
- IL #636-114141
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1184686909. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
297
Distinct HCPCS
5
Medicare allowed
$29,078
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 161 | 100 | $91 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 63 | 49 | $128 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 45 | 27 | $36 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 15 | 15 | $191 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 13 | 13 | $141 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 59. This provider delivers 5.0× the peer median.Open Payments
Industry payments received
All-time total
$717
Transactions
18
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $165.28 | |
| Novo Nordisk Inc | 4 | $154.51 | |
| Lilly USA, LLC | 3 | $112.61 | |
| Insulet Corporation | 2 | $103.27 | |
| Abbott Laboratories | 3 | $44.61 | |
| JAZZ PHARMACEUTICALS INC. | 1 | $39.24 | |
| EMD Serono, Inc. | 1 | $31.50 | |
| Corcept Therapeutics | 1 | $28.61 | |
| AstraZeneca Pharmaceuticals LP | 1 | $19.82 | |
| RECORDATI_RARE_DISEASES_INC. | 1 | $18.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
931
Patients
166
Total drug cost
$370,777
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 303 | 58 | $3,012 |
| Ozempic (Semaglutide) | Brand | 106 | 27 | $153,819 |
| Metformin Hcl | Generic | 95 | 27 | $1,130 |
| Hydrocortisone | Generic | 57 | 11 | $1,488 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 55 | 14 | $40,798 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 44 | 18 | $32,575 |
| Synthroid (Levothyroxine Sodium) | Brand | 44 | 0 | $2,633 |
| Jardiance (Empagliflozin) | Brand | 40 | 11 | $44,556 |
| Methimazole | Generic | 30 | 0 | $400 |
| Basaglar Kwikpen U-100 (Insulin Glargine,hum.Rec.Anlog) | Brand | 29 | 0 | $17,715 |